Business
Hampton Securities Limited Announces Closing of $2.35 Million LIFE Private Placement of Units for 01 Quantum Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATE...
About this update from Hampton Financial Corp.
[{"type":"text","content":"Hampton Securities Limited Announces Closing of $2.35 Million LIFE Private Placement of Units for 01 Quantum Inc.\n\n\n\n\n NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES\n \n\n\n TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Hampton Securities Limited (\"Hampton” or the “Agent”) is pleased to announce the closing of a commercially reasonable efforts private placement of 4,892,499 units (the \"Units\") at a price of $0.48 per Unit (the \"Offering Price\") of 01 Quantum Inc. (TSXV:ONE) (the “Company”), being one of the first-to-market, enterprise level cybersecurity providers for the quantum computing era.\n \n\n Each Unit consists of one Common Share of the Company (each a \"Common Share\") and one-half of one Common Share purchase warrant of the Company (each full warrant, a \"Warrant\" and collectively the \"Warrants\"). Each Warrant is exercisable at $0.75 for a period of thirty-six (36) months from the closing of the Offering.\n \n\n Hampton acted as the sole agent on the Offering which was completed on a commercially reasonable efforts basis. As consideration for its services, Hampton received a cash fee equal to 7% of the gross proceeds of the Offering. In addition, the Company issued to the Agent 342,475 compensation options (the “Compensation Options”). Each Compensation Option entitles the Agent to purchase one Common Share at the Offering Price for a period of thirty-six (36) months from the closing of the Offering. The Compensation Options are non-transferable and the securities issued on exercise of the Compensation Options are subject to a hold period that expires four months and one day after issuance.\n \n\n The Company intends to use the net proceeds from the Offering to advance its product development initiatives, expand its product development and sales and marketing teams, accelerate commercialization efforts of its technology and commercial applications, and general working capital needs as further described in the Offering Document (as defined below).\n \n\n The Company relied on Part 5A of National Instrument 45-106 –\n \n Prospectus Exemptions\n \n , as amended by Coordinated Blanket Order 45-935 –\n \n Exemptions from Certain Conditions of the Listed Issuer Financing Exemption,\n \n for the issu...